Literature DB >> 174881

[Bactericidal dosie-activity relationships with E. coli, K. pneumoniae and Staph. aureus (author's transl)].

P M Shah, W Stille.   

Abstract

In investigations into the dosis-activity relationships of bactericidal antibiotics used against E. coli, K. pneumoniae and Staph. aureus four types of activity could be demonstrated. The penicillin type shows almost no improvement in bactericidal activity despite increasing the dosage above a certain level. An increase in concentration of aminoglycoside antibiotics led to a more rapid killing of the bacteria. In cefalotin there was a linear dosis-activity relationship: rising concentrations of antibiotics led to an ever increasing bactericidal effect. The paradoxical bactericidal effect ("Eagle effect'') described for penicillin G with enterococci could not be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 174881     DOI: 10.1055/s-0028-1104083

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  9 in total

Review 1.  Continuous infusion of beta-lactam antibiotics.

Authors:  W A Craig; S C Ebert
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

2.  Comparative bactericidal activity of ceftazidime against isolates of Pseudomonas aeruginosa as assessed in an in vitro pharmacodynamic model versus the traditional time-kill method.

Authors:  M Manduru; L B Mihm; R L White; L V Friedrich; P A Flume; J A Bosso
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

3.  In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  M Manduru; L B Mihm; R L White; L V Friedrich; P A Flume; J A Bosso
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

4.  Reverse inoculum effect in bactericidal activity and other variables affecting killing of group B streptococci by penicillin.

Authors:  L Jokipii; P Brander; A M Jokipii
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

Review 5.  How to Treat Sepsis in the Background of Resistance?: Role of Pharmacodynamics / Pharmacokinetics in Treating Sepsis.

Authors:  Mohit Agrawal; Ashok Rattan
Journal:  Indian J Pediatr       Date:  2020-01-14       Impact factor: 1.967

6.  Antibacterial kinetics of ampicillin against Escherichia coli under simulated in vivo conditions.

Authors:  J E Fuglesang; T Bergan
Journal:  Infection       Date:  1982-01       Impact factor: 3.553

Review 7.  A retrospective analysis of pharmacokinetic-pharmacodynamic parameters as indicators of the clinical efficacy of ceftizoxime.

Authors:  A Sánchez-Navarro; C I Colino; M M Sánchez Recio
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 8.  Drug permeation and metabolism in Mycobacterium tuberculosis: Prioritising local exposure as essential criterion in new TB drug development.

Authors:  Lloyd Tanner; Paolo Denti; Lubbe Wiesner; Digby F Warner
Journal:  IUBMB Life       Date:  2018-06-22       Impact factor: 3.885

9.  Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics.

Authors:  Goue Denis Gohore Bi; Jun Li; Fahima Nekka
Journal:  Theor Biol Med Model       Date:  2009-06-26       Impact factor: 2.432

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.